Sg Americas Securities, LLC Ionis Pharmaceuticals Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,419 shares of IONS stock, worth $269,532. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,419

Holding current value

$269,532

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$40.06 - $51.86 $297,205 - $384,749	7,419 New	7,419 $297,000
Q1 2024 May 06, 2024	BUY	$42.03 - $53.55 $61,069 - $77,808	1,453 Added 23.71%	7,582 $329,000
Q4 2023 Jan 12, 2024	SELL	$43.39 - $51.63 $1.54 Million - $1.83 Million	-35,442 Reduced 85.26%	6,129 $310,000
Q3 2023 Oct 13, 2023	BUY	$38.5 - $47.13 $850,003 - $1.04 Million	22,078 Added 113.26%	41,571 $1.89 Million
Q2 2023 Jul 10, 2023	BUY	$34.73 - $43.33 $676,991 - $844,631	19,493 New	19,493 $800,000
Q3 2022 Oct 31, 2022	SELL	$36.54 - $48.66 $2.19 Million - $2.91 Million	-59,859 Reduced 82.5%	12,698 $562,000
Q2 2022 Jul 29, 2022	BUY	$31.71 - $43.0 $1.93 Million - $2.62 Million	60,966 Added 525.98%	72,557 $2.69 Million
Q1 2022 Apr 29, 2022	SELL	$29.88 - $37.04 $40,069 - $49,670	-1,341 Reduced 10.37%	11,591 $429,000
Q4 2021 Feb 07, 2022	SELL	$25.61 - $35.1 $173,866 - $238,293	-6,789 Reduced 34.43%	12,932 $394,000
Q3 2021 Nov 01, 2021	BUY	$33.54 - $40.55 $284,150 - $343,539	8,472 Added 75.31%	19,721 $661,000
Q2 2021 Aug 12, 2021	SELL	$34.54 - $47.25 $1.19 Million - $1.63 Million	-34,559 Reduced 75.44%	11,249 $449,000
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $611,888 - $918,049	14,394 Added 45.82%	45,808 $2.06 Million
Q4 2020 Feb 04, 2021	SELL	$45.3 - $60.27 $1.03 Million - $1.37 Million	-22,721 Reduced 41.97%	31,414 $1.78 Million
Q3 2020 Nov 09, 2020	BUY	$47.45 - $62.95 $2.27 Million - $3.01 Million	47,769 Added 750.38%	54,135 $2.57 Million
Q2 2020 Jul 20, 2020	SELL	$46.85 - $61.05 $287,518 - $374,663	-6,137 Reduced 49.08%	6,366 $375,000
Q1 2020 Apr 30, 2020	BUY	$41.6 - $63.4 $180,460 - $275,029	4,338 Added 53.13%	12,503 $591,000
Q4 2019 Jan 28, 2020	SELL	$53.85 - $65.27 $109,907 - $133,216	-2,041 Reduced 20.0%	8,165 $493,000
Q3 2019 Nov 04, 2019	SELL	$59.06 - $72.15 $26,813 - $32,756	-454 Reduced 4.26%	10,206 $611,000
Q2 2019 Jul 29, 2019	BUY	$62.09 - $86.14 $498,458 - $691,531	8,028 Added 305.02%	10,660 $685,000
Q1 2019 Apr 29, 2019	SELL	$52.92 - $81.17 $544,705 - $835,482	-10,293 Reduced 79.64%	2,632 $214,000
Q4 2018 Feb 01, 2019	BUY	$43.37 - $59.54 $408,675 - $561,045	9,423 Added 269.07%	12,925 $699,000
Q3 2018 Nov 06, 2018	SELL	$42.88 - $53.7 $3.23 Million - $4.04 Million	-75,242 Reduced 95.55%	3,502 $181,000
Q2 2018 Aug 07, 2018	BUY	$40.53 - $50.7 $2.84 Million - $3.55 Million	70,082 Added 809.07%	78,744 $3.28 Million
Q1 2018 May 03, 2018	BUY	$44.08 - $55.05 $381,820 - $476,843	8,662 New	8,662 $382,000
Q4 2017 Jan 24, 2018	SELL	$50.3 - $64.39 $118,003 - $151,058	-2,346 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$45.56 - $59.57 $106,883 - $139,751	2,346	2,346 $119,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.16B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Ionis Pharmaceuticals Inc Transaction History